This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
per share, the offering included 1,300,000 ordinary shares, which began trading on the Nasdaq Global Market under the ticker symbol GELS on October 29, 2024. With an expanding patent portfolio and partnerships in human and animal health, Gelteq promotes therapeutic efficacy and patient adherence across diverse health markets.
In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Key innovation: Leading companies in nanoparticles for drugdelivery. Bristol-Myers Squibb is the leading patent filer in nanoparticles for drugdelivery.
FDA recently released a much-anticipated draft guidance to address these frequent questions: Essential DrugDelivery Outputs for Devices Intended to Deliver Drugs and Biological Products. Drugdelivery includes successful product preparation and the initiation, progression, and completion of dose delivery.
Trading began on the Nasdaq Capital Market under the ticker “PLRZ” on October 29, 2024. Additionally, a collaboration with NurExone is creating an intranasal delivery system for exosome-based therapies targeting spinal cord injuries, with potential expansion into other neurological uses. The IPO, priced at $4.38
Antares Pharma's auto-injector technology is of particular interest to Halozyme, which believes that the various markets to which it could be applied represent billions of dollars in potential sales.
Amazon Pharmacy launched a pair of TV spots last month to showcase the ease of its drugdelivery service for consumers. The service is an expansion of Amazon’s acquisition of PillPack in 2018, which provided a foundation for Amazon to enter the pharmaceutical market. billion this year. billion by 2029.
Hence, a precision therapy or we can say a target therapy (involving intracellular drugdelivery) is much needed to all the patients suffering from cancer. Here is how the intracellular drugdelivery comes into action for majority of the fatal diseases that requires target therapy. The answer is yes.
Genentech’s ocular implant drugdelivery system for treatment of macular degeneration has received approval from the US Food and Drug Administration (FDA). Susvimo delivers ranibizumab via a port delivery system into a surgically placed implant in the eye, allowing for continuous delivery of the drug.
SMi presents the Inaugural: Transdermal and Microneedle DrugDelivery Conference. Latest innovations in drugdelivery beyond the needle. SMi is proud to present the Transdermal and Microneedle DrugDelivery Conference, taking place on the 24th to 25th January 2022, in London. pharmaphorum .
Over the last two decades, the pharmaceutical industry has observed a paradigm shift from conventional drugdelivery strategies to the long-acting drugdelivery (LADD) of products to treat several disease indications, such as ophthalmic disorders, oncological disorders, neurological disorders and infectious diseases.
As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drugdelivery and prefilled syringe market in the coming years. The injectable drugdeliverymarket is expected to rise at a compound annual growth rate of 12.9%
Stakeholders Involved in intranasal therapeutics and drugdelivery domain. Most of the drugs (55%) are small molecules. Millions of dollars are being invested in funding the initiatives of various players engaged in the intranasal therapeutics and drugdelivery domain. Roots Analysis Report. Web: [link].
Contract marketing companies support pharmaceutical companies in creating, improving, and maintaining their brand, as well as reducing risk, and ensuring better product placement in the market. Identifying the top commercial dose (non-sterile) companies in contract marketing.
According to Precedence Research, the global injectable drugdeliverymarket reached U.S. Simplifying the administration of complex injectables for reconstitution, liquid/liquid mixing and the sequential delivery of multiple liquid drugs.
DrugDelivery in Cancer 2021: Technologies, Markets & 238 Company Profiles – ResearchAndMarkets.com DrugDelivery in Cancer 2021: Technologies, Markets & 238 Company Profiles – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “DrugDelivery in Cancer – Technologies, Markets & Companies” report (..)
Pulmonary DrugDelivery Systems Market Forecasts to 2026: A US$56.942 Billion Market by 2026 – ResearchAndMarkets.com Pulmonary DrugDelivery Systems Market Forecasts to 2026: A US$56.942 Billion Market by 2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Pulmonary DrugDelivery Systems Market – … Continue (..)
CordenPharma, a global CDMO manufacturing complex drug substances and lipid nanoparticles (LNPs), has signed a partnership agreement with Certest, a Spanish company specializing in drugdelivery and API synthesis.
North America DrugDeliveryMarket Research Report 2021 with Forecasts to 2026 – ResearchAndMarkets.com North America DrugDeliveryMarket Research Report 2021 with Forecasts to 2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “North America DrugDeliveryMarket – Forecasts from 2021 to … Continue reading (..)
2020 Insights on the Global Markets and Technologies for Advanced DrugDelivery Systems – ResearchAndMarkets.com 2020 Insights on the Global Markets and Technologies for Advanced DrugDelivery Systems – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Markets and Technologies for Advanced DrugDelivery … (..)
DUBLIN–(BUSINESS WIRE)–The “Intranasal DrugDelivery – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Amid the COVID-19 crisis, the global market for Intranasal DrugDelivery estimated at US$44.7
Global Biotechnology, Drug Development and DrugDelivery Systems Nanoparticles Markets, 2019-2020 & 2025 – ResearchAndMarkets.com Global Biotechnology, Drug Development and DrugDelivery Systems Nanoparticles Markets, 2019-2020 & 2025 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Nanoparticles in Biotechnology, (..)
DUBLIN–(BUSINESS WIRE)–The “Nasal DrugDelivery Technology – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Nasal DrugDelivery Technology Market to Reach $73.3
$158 Billion DrugDelivery Systems (DDS) Markets – Global Forecast to 2027 – Necessity of DrugDelivery Systems for Enhancing Therapeutic Efficiency and Safety Profile of Drugs – ResearchAndMarkets.com $158 Billion DrugDelivery Systems (DDS) Markets – Global Forecast to … Continue reading →
Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drugdelivery methods across patient groups.
Global Pharmaceutical DrugDeliveryMarket Forecast to 2026: 3M, Amgen, Eli Lilly and Bayer Dominate – ResearchAndMarkets.com Global Pharmaceutical DrugDeliveryMarket Forecast to 2026: 3M, Amgen, Eli Lilly and Bayer Dominate – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical DrugDelivery … (..)
Being hailed as the world’s shortest and thinnest needle for insulin injection, Droplet Micron has recently been introduced into the pen needle market by HTL (High Tech Lab)-STREFA, Inc. This highlights the importance of optimal drugdelivery, including the injection experience itself.
Novel DrugDelivery Systems (NDDS) | Global Market Trajectory & Analytics | Industry Worth $28.1 Billion by 2026 – ResearchAndMarkets.com Novel DrugDelivery Systems (NDDS) | Global Market Trajectory & Analytics | Industry Worth $28.1
LONDON–(BUSINESS WIRE)–#GlobalNeedlefreeDrugDeliveryDevicesMarket–Technavio has been monitoring the needle-free drugdelivery devices market and it is poised to grow by USD 10.23 bn during 2020-2024, progressing at a CAGR of over 4% during the forecast period.
Global Topical DrugDeliveryMarket Report 2021: Market to Reach $129.9 Billion – ResearchAndMarkets.com Global Topical DrugDeliveryMarket Report 2021: Market to Reach $129.9 Billion by 2027 – Semi-Solid Formulations Segment to Account for $51.1
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content